A multicenter clinical study on wearable percutaneous acupoint electrical stimulation wristband for the treatment of moderate to severe nausea and vomiting after general anesthesia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400084329

Enrollment

Unknown

Registered

2024-05-14

Start date

2024-05-20

Completion date

Unknown

Last updated

2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting after general anesthesia

Interventions

Control group: Metoclopramide iv.+ Model wearable percutaneous acupoint electrical stimulation bracelet

Test group: Saline iv.+ Wearable percutaneous acupoint electrical stimulation bracelet

Eligibility

Sex/Gender

Female

Age

25 Years to 55 Years

Inclusion criteria

Inclusion criteria: Female patients under general anesthesia, aged 25-55 years, with ASA I-II grade, who developed moderate to severe PONV (VAS score = 4) after surgery, and sign an informed consent form for the trial.

Exclusion criteria

Exclusion criteria: (1) Patients with severe liver and kidney dysfunction; (2) Patients who refuse acupoint electrical stimulation therapy; (3) People who are not suitable for the use of Metoclopramide; (4) Unstable vital signs before enrollment.

Design outcomes

Primary

Measure	Time frame
success rate of relieve postoperative moderate to severe nausea and vomiting;success rate of relieve PONV within 2 hours after cross intervention in an insensitive population undergoing initial intervention treatment ;	—

Secondary

Measure	Time frame
recurrence rate of moderate to severe PONV within 24 hours after intervention treatment;	—

Countries

China

Contacts

Public Contactli yonghua

Shanghai Changzheng hospital

liyonghua1207@126.com+86 137 9543 9726

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026